abstracts

Sarcopenia is Associated with Social Determinants of Health in Patients with Inflammatory Bowel Disease

BACKGROUND: Sarcopenia is defined as the loss of skeletal muscle mass and is a modifiable condition that affects between 27 to 61% of patients with inflammatory bowel disease (IBD). Socia...

Ayushi Jain ;

Kavita Ramnath ;

Laurie Rosales ;

Beth Kulow ;

Jacob Skeans ;

Madalina Butnariu ;

Adeeti Chiplunker ;

Anita Afzali ;

12/15/2022

P064 Association Between Crohn's Disease (CD) and Transient IgM and IgG Immunodeficiency—Diagnostic and Management Challenges

CASE: Background: CD is an inflammatory disease that predominantly affects the gastrointestinal tract and has a progressive course. Immunodeficiencies can occur by altering di...

Claudio Coy ;

Daniela Magro ;

Secundo Tirzah Lopes ;

Imbrizi Marcello Rabello ;

Daniel Lahan-Martins ;

Miriam Trevisan ;

Antonio de Pinho Jr.;

Virginia Cabral ;

12/15/2021

P075 Urgency and its Association with Quality of Life and Clinical Outcomes in Ulcerative Colitis Patients

BACKGROUND: Urgency, the immediate need to defecate, is common in ulcerative colitis (UC). The frequently used patient reported outcome (PRO)-2 for UC includes only rectal ble...

Millie D. Long , MD, MPH;

Jared Sninsky ;

Edward L. Barnes ;

Xian Zhang ;

12/15/2021

P065 A One-Time Education for Gastroenterologists Regarding Osteoporosis Screening for IBD Patients Improves Provider Knowledge But Not Screening Rates

BACKGROUND: Inflammatory Bowel Disease (IBD) is a chronic gastrointestinal inflammatory condition and has been increasing in prevalence in the United States, with a 30-40% inc...

Subin Chirayath ;

Dhruv Patel ;

Dhruvanshu Patel ;

Parampreet Kaur ;

Yecheskel Schneider ;

12/15/2021

P076 The Role of Dual Biologic Therapy in Inflammatory Bowel Disease

BACKGROUND: As the prevalence of complex inflammatory bowel disease and extraintestinal manifestations continue to rise, more patients are requiring complex treatment regimens...

Erin Forster , MD, MPH;

Molly Stone ;

Margaret Morrison ;

12/15/2021

P066 Real-World Experience of Ustekinumab in Crohn's Disease Patients With Prior Anti-TNF Therapy at a Tertiary Care Hospital

BACKGROUND: Ustekinumab (UST) is a monoclonal antibody against the p40 subunit of IL-12/23. It is approved for the treatment of moderate to severe Crohn's disease (CD) and Ulc...

Kartikeya Tripathi ;

Kevin Groudan ;

Jean Chalhoub ;

Arushika Yedla ;

Rohit Singhania ;

12/15/2021

P077 Incidence of Colonic Strictures — A Systematic Review and Meta-analysis

BACKGROUND: Intestinal strictures are a complication of the inflammatory bowel diseases (IBD, including ulcerative colitis (UC) and Crohn’s disease (CD)) that can lead to bowe...

Abhishek Bhurwal , MD;

Roohi Patel ;

Hemant Mutneja ;

Darren Seril ;

John H. Stroger Jr.;

12/15/2021

P067 Immune Checkpoint Inhibitor Colitis in a Community-Based Hospital System

BACKGROUND: Immune checkpoint inhibitors (ICIs) have significantly changed the oncologic treatment landscape for a wide array of cancers over the past few decades. While these...

Aaron Rampersad ;

Gary Abrams ;

Christina Bauer ;

12/15/2021

P068 Racial and Socioeconomic Disparities in Acute Care Utilization in a National Cohort of Veterans With IBD

BACKGROUND: Hospitalizations for Black patients with inflammatory bowel disease (IBD) have increased in recent decades though our understanding of disease behavior in Black pa...

Alexander Booth ;

Everette Keller ;

Erin Forster , MD, MPH;

Robert Axon ;

Gayenell Magwood ;

Thomas Curran ;

12/15/2021

P069 The Unrelenting Ulcer

CASE: Inflammatory Bowel Disease (IBD) is becoming more common in an increasingly diverse population. Exposure history is important, especially when prescribing immunosuppress...

Emmanuelle Williams ;

Michelle Rosario ;

12/15/2021

abstracts

Follow Us on Twitter!

Specialties

Events

Year Round Education

HMP Global Products